Authors:
BAZINREDUREAU MI
RENARD CB
SCHERRMANN JMG
Citation: Mi. Bazinredureau et al., PHARMACOKINETICS OF HETEROLOGOUS AND HOMOLOGOUS IMMUNOGLOBULIN-G, F(AB')(2) AND FAB AFTER INTRAVENOUS ADMINISTRATION IN THE RAT, Journal of Pharmacy and Pharmacology, 49(3), 1997, pp. 277-281
Authors:
CANO NJ
SABOURAUD AE
DEBRAY M
SCHERRMANN JMG
Citation: Nj. Cano et al., DOSE-DEPENDENT REVERSAL OF DIGOXIN-INHIBITED ACTIVITY OF AN IN-VITRO NA(-SPECIFIC ANTIBODY()K(+)ATPASE MODEL BY DIGOXIN), Toxicology letters, 85(2), 1996, pp. 107-111
Authors:
GRENELEROUGE NAM
BAZINREDUREAU MI
DEBRAY M
SCHERRMANN JMG
Citation: Nam. Grenelerouge et al., INTERSPECIES SCALING OF CLEARANCE AND VOLUME OF DISTRIBUTION FOR DIGOXIN-SPECIFIC FAB, Toxicology and applied pharmacology, 138(1), 1996, pp. 84-89
Authors:
CHAPPEY ON
NIEL E
DEBRAY M
WAUTIER JL
SCHERRMANN JMG
Citation: On. Chappey et al., EFFLUX OF INTRACELLULAR COLCHICINE IN LYMPHOCYTES WITH COLCHICINE-SPECIFIC FAB FRAGMENTS, The Journal of pharmacology and experimental therapeutics, 274(3), 1995, pp. 1072-1076
Citation: Cv. Thanhbarthet et al., DEVELOPMENT OF A SENSITIVE RADIOIMMUNOASSAY FOR FAB FRAGMENTS - APPLICATION TO FAB PHARMACOKINETICS IN HUMANS, Pharmaceutical research, 10(5), 1993, pp. 692-696